Download
HTML Embed
HTML EMBED
Click to Copy

Latest Episodes

Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Make Me Smart with Kai and Molly
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Sign up for "Econ Extra Credit with David Brancaccio" Here

The Ebola outbreak is over, but the hunt for a vaccine continues

by Marketplace Contributor Feb 25, 2016
How do you find a cure for a deadly diseases when you’ve been successful at stopping it?
At Emory University’s Hope Clinic in Atlanta, researchers are testing blood and plasma samples from people who received an experimental Ebola vaccine, now licensed to British drug company GlaxoSmithKline.
Michell Eloy/WABE

Early results suggest an effective Ebola vaccine

by Dan Gorenstein Jul 31, 2015
The treatment provided total protection to people in close contact with patients.

BARDA: The venture capital firm buried in the U.S. government

by Dan Gorenstein Oct 30, 2014
HHS is paying for expedited drug research on Ebola.

The economics behind the rush for an Ebola vaccine

by Dan Gorenstein Oct 22, 2014
Believe it or not, experts say the profit motive is secondary.